Prot # 08-266/CS0M230CUS09T: Phase II Study of Monthly SOM230C for Recurrent or Progressive Meningioma

  • Raizer, Jeffrey J (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date3/25/10 → 6/30/17

Funding

  • Dana-Farber Cancer Institute (08-266/CS0M230CUS09T // 08-266/CS0M230CUS09T)
  • Novartis Pharmaceuticals Corporation (08-266/CS0M230CUS09T // 08-266/CS0M230CUS09T)